News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Pharming Group Gets U.S. Okay for Prodarsan Trial
August 14, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Biotechnology company Pharming Group on Friday said the U.S. Food and Drug Administration accepted its investigational new drug application for Prodarsan, permitting a clinical trial to proceed.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 1
MORE ON THIS TOPIC
Business
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
October 21, 2026
·
1 min read
·
Jef Akst
Weight loss
Novo’s CagriSema achieves 25% weight loss in women, driven by younger patients
October 21, 2026
·
2 min read
·
Nick Paul Taylor
Neuropsychiatric disorders
Rapport ekes out bipolar mania win as lead asset ‘just hits’ in mid-stage trial
October 20, 2026
·
3 min read
·
Heather McKenzie
Inflammatory bowel disease
Gilead’s ‘highly competitive’ mid-stage ulcerative colitis data ‘validate’ I&I push
October 20, 2026
·
3 min read
·
Tristan Manalac